Largest pharmaceutical companies in the United States by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 36 pharmaceutical companies in the United States ranked by revenue, at DKK 641.8B, ahead of Eli Lilly (DKK 444.1B) and Merck & Co (DKK 443B). Figures as of 20 Nov 2026, 23:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 36
- First
- Johnson & JohnsonDKK 641.8B
- Median
- DKK 9.4B
- Combined market value
- DKK 25.46T
- Countries
- 1
- Not ranked
- 8no revenue on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | DKK 641.8B | DKK 4.44T | DKK 1,843.04 | 1.25% up | 31% up | ||
| 2 | Eli LillyLLY · Health Care | DKK 444.1B | DKK 8.18T | DKK 9,179.48 | 0.30% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | DKK 443B | DKK 2.25T | DKK 911.19 | 0.69% up | 36% up | ||
| 4 | PfizerPFE · Health Care | DKK 426.4B | DKK 1.06T | DKK 186.71 | 0.51% down | 10% up | ||
| 5 | AbbVieABBV · Health Care | DKK 416.8B | DKK 3.45T | DKK 1,950.22 | 0.94% up | 20% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | DKK 328.4B | DKK 819B | DKK 400.67 | 0.79% up | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | DKK 302.1B | DKK 1.22T | DKK 701.86 | 0.84% down | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | DKK 97.7B | DKK 649B | DKK 6,273.77 | 0.19% down | 22% up | ||
| 9 | ViatrisVTRS · Health Care | DKK 97.4B | DKK 153.4B | DKK 133.76 | 1.26% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | DKK 81.8B | DKK 889.8B | DKK 3,509.45 | 1.08% down | 22% up | ||
| 11 | ZoetisZTS · Health Care | DKK 64.5B | DKK 219B | DKK 539.07 | 2.08% down | 34% down | ||
| 12 | Elanco Animal HealthELAN · Health Care | DKK 32.1B | DKK 87.7B | DKK 175.40 | 2.09% down | 18% up | ||
| 13 | Alnylam PharmaceuticalsALNY · Health Care | DKK 25.3B | DKK 131.3B | DKK 980.02 | 2.71% down | 66% down | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | DKK 22B | DKK 79.7B | DKK 411.65 | 1.64% down | 12% up | ||
| 15 | United TherapeuticsUTHR · Health Care | DKK 21.7B | DKK 161B | DKK 3,780.04 | 0.78% down | 18% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | DKK 20.6B | DKK 50.1B | DKK 143.92 | 1.26% down | 79% up | ||
| 17 | Royalty PharmaRPRX · Health Care | DKK 16.2B | DKK 268.2B | DKK 466.43 | 1.08% up | 74% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | DKK 11.8B | DKK 32.1B | DKK 384.46 | 3.27% down | 26% down | ||
| 19 | Legend BiotechLEGN · Health Care | DKK 7B | DKK 20.2B | DKK 103.92 | 5.28% down | 43% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 6.5B | DKK 60B | DKK 2,583.26 | 4.45% down | 28% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | DKK 6.4B | DKK 30.2B | DKK 181.12 | 2.35% down | 64% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 5.7B | DKK 39.9B | DKK 281.90 | 5.22% down | 8% up | ||
| 23 | Corcept TherapeuticsCORT · Health Care | DKK 5.2B | DKK 47.4B | DKK 433.52 | 2.09% down | 16% down | ||
| 24 | Axsome TherapeuticsAXSM · Health Care | DKK 4.4B | DKK 46.4B | DKK 881.48 | 4.66% down | 9% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | DKK 4.2B | DKK 65.2B | DKK 431.61 | 2.37% down | 103% up | ||
| 26 | InsmedINSM · Health Care | DKK 4.1B | DKK 211.3B | DKK 963.05 | 2.17% down | 27% down | ||
| 27 | Mirum PharmaceuticalsMIRM · Health Care | DKK 3.6B | DKK 42.8B | DKK 655.05 | 0.65% up | 35% up | ||
| 28 | BridgeBio PharmaBBIO · Health Care | DKK 3.4B | DKK 100.9B | DKK 518.08 | 2.75% down | 15% up | ||
| 29 | Travere TherapeuticsTVTX · Health Care | DKK 3.3B | DKK 30.7B | DKK 320.27 | 2.69% down | 39% up | ||
| 30 | Ligand PharmaceuticalsLGND · Health Care | DKK 1.8B | DKK 39.1B | DKK 1,954.65 | 0.03% down | 44% up | ||
| 31 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 1.3B | DKK 53.1B | DKK 765.64 | 3.80% down | 15% up | ||
| 32 | CytokineticsCYTK · Health Care | DKK 599.9M | DKK 48.2B | DKK 346.03 | 1.32% down | 21% down | ||
| 33 | Protagonist TherapeuticsPTGX · Health Care | DKK 313.6M | DKK 54B | DKK 827.24 | 2.11% down | 45% up | ||
| 34 | Dianthus TherapeuticsDNTH · Health Care | DKK 13.9M | DKK 32.4B | DKK 576.14 | 0.33% down | 105% up | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | DKK 0 | DKK 60.5B | DKK 636.92 | 4.26% down | 302% up | ||
| 36 | Praxis Precision MedicinesPRAX · Health Care | DKK 0 | DKK 57.2B | DKK 2,047.19 | 3.37% down | 83% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8142 DKK). 8 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by revenue?
Johnson & Johnson (DKK 641.8B), Eli Lilly (DKK 444.1B) and Merck & Co (DKK 443B) are the top three of the 36 pharmaceutical companies in the United States ranked by revenue as of 20 Nov 2026, 23:14 UTC.
How many pharmaceutical companies in the United States are in this ranking?
36 are ranked by revenue. 8 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 36 pharmaceutical companies in the United States ranked by revenue have a combined market value of DKK 25.46T as of 20 Nov 2026, 23:14 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.